Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma

Clinical trial NCT03215719 · RECRUITING

Trial details

NCT number: NCT03215719
Sponsor: NYU Langone Health
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oropharyngeal Carcinoma HPV Positive Oropharyngeal Squamous Cell Carcinoma

Start date: 2017-10-18
Primary completion: 2028-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.